ADC Therapeutics SA Number Of Share Options Exercised In Share-based Payment Arrangement
ADC Therapeutics SA (ADCT) reported Number Of Share Options Exercised In Share-based Payment Arrangement of 0 shares for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-15.
Discontinued › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement · last filed 2023-03-15
- ADC Therapeutics SA number of share options exercised in share-based payment arrangement for the quarter ending 2021-12-31 was 13.90K shares.
- ADC Therapeutics SA number of share options exercised in share-based payment arrangement for the quarter ending 2021-09-30 was 14.96K shares.
- ADC Therapeutics SA number of share options exercised in share-based payment arrangement for the quarter ending 2021-06-30 was 12.36K shares.
- ADC Therapeutics SA number of share options exercised in share-based payment arrangement for the quarter ending 2021-03-31 was 155.00 shares.
| Period end | Number Of Share Options Exercised In Share-based Payment Arrangement | Number Of Share Options Exercised In Share-based Payment Arrangement as first filed | Number Of Share Options Exercised In Share-based Payment Arrangement 3 month | Number Of Share Options Exercised In Share-based Payment Arrangement 6 month | Number Of Share Options Exercised In Share-based Payment Arrangement 9 month | Number Of Share Options Exercised In Share-based Payment Arrangement 12 month |
|---|---|---|---|---|---|---|
| 2022-12-31 | 0.00 shares 20-F · filed 2023-03-15 | |||||
| 2021-12-31 | 13.90K shares derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | 28.86K shares derived: sum of 2 quarters · filed 2023-03-15 | 41.23K shares derived: sum of 3 quarters · filed 2023-03-15 | 41.38K shares 20-F · filed 2023-03-15 | ||
| 2021-09-30 | 14.96K shares derived: 6-K 9 month − 6-K 6 month · filed 2021-11-02 | 27.33K shares derived: sum of 2 quarters · filed 2021-11-02 | 27.48K shares 6-K · filed 2021-11-02 | |||
| 2021-06-30 | 12.36K shares derived: 6-K 6 month − 6-K 3 month · filed 2021-08-03 | 12.52K shares 6-K · filed 2021-08-03 | ||||
| 2021-03-31 | 155.00 shares 6-K · filed 2021-05-06 | |||||
| 2020-12-31 | 2.90K shares 20-F · filed 2023-03-15 | |||||
| 2020-12-29 | 517.00 shares 20-F · filed 2021-03-18 | |||||
| 2020-12-16 | 517.00 shares 20-F · filed 2021-03-18 | |||||
| 2020-12-14 | 2.90K shares 20-F · filed 2022-03-17 | 1.86K shares 20-F · filed 2021-03-18 | ||||
| 2019-12-31 | 0.00 shares 20-F · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |